Emerging Technology and Therapeutics Report on Proteomics for Cancer and Cardiovascular Disease: Indefinite Delivery/Indefinite Quantity Analytic and Operational Support for the Engagement of the Public and Patients
Through this TORFP, PCORI sought contractors to produce an evidence map and narrative review with key-informant interviews on the use of proteomics for cancer and cardiovascular disease. These products shall evaluate the scope of evidence available in the published and gray literature and discuss the results in the context of any relevant regulatory, practice, and/or systems issues.
Award Date: March 16, 2020
Successful Offeror: RAND Corporation
Award Amount: $163,834
Posted: June 4, 2020
What's Happening at PCORI?
The Patient-Centered Outcomes Research Institute sends weekly emails about opportunities to apply for funding, newly funded research studies and engagement projects, results of our funded research, webinars, and other new information posted on our site.